The Cost Effectiveness of Two New Antiepileptic Therapies in the Absence of Direct Comparative Data: A First Approximation

Author： van Hout B.A.   Gagnon D.D.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.5, 2003-01, pp. : 315-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma

By Ya-Chen Tina Shih  

PharmacoEconomics, Vol. 25, Iss. 7, 2007-01 ,pp. : 577-590

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Therapies for Atrial Fibrillation: A Review

By Teng M.P.  

PharmacoEconomics, Vol. 18, Iss. 4, 2000-10 ,pp. : 317-333

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Cholesterol-Lowering Therapies in Spain

By Plans-Rubió Pedro  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 177-188

Adis International

Access to resources Recommend Favorite

Cost effectiveness of cardiovascular therapies hugely variable

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 528, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Helicobacter pylori Eradication Therapies in Patients with Duodenal Ulcer: An Analysis of Triple Therapy Versus Two Dual Therapy Alternatives

By Tennvall G.R.  

PharmacoEconomics, Vol. 16, Iss. 3, 1999-09 ,pp. : 297-306

Adis International

Access to resources Recommend Favorite